Adenovirus as expression vectors and recombinant vaccinesGRAHAM, F. L.Trends in biotechnology (Regular ed.). 1990, Vol 8, Num 4, pp 85-87, issn 0167-7799Article

Growth of 293 cells in suspension cultureGRAHAM, F. L.Journal of general virology. 1987, Vol 68, Num 3, pp 937-940, issn 0022-1317Article

Recombinant human adenoviruses containing hybrid adenovirus type 5 (Ad5)/Ad12 E1A genes: characterization of hybrid E1A proteins and analysis of transforming activity and host rangeJELINEK, T; GRAHAM, F. L.Journal of virology. 1992, Vol 66, Num 7, pp 4117-4125, issn 0022-538XArticle

Adenoviruses with nonidentical terminal sequences are viableLIPPE, R; GRAHAM, F. L.Journal of virology. 1989, Vol 63, Num 12, pp 5133-5141, issn 0022-538XArticle

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 studyTRUDEL, S; LI, Z; DODGSON, C et al.Leukemia. 2001, Vol 15, Num 5, pp 846-854, issn 0887-6924Article

Adenoviral vector-mediated interleukin-10 expression in vivo : intramuscular gene transfer inhibits cytokine responses in endotoxemiaXING, Z; OHKAWARA, Y; JORDANA, M et al.Gene therapy (Basingstoke). 1997, Vol 4, Num 2, pp 140-149, issn 0969-7128Article

Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytesMORSY, M. A; ALFORD, E. L; BETT, A et al.The Journal of clinical investigation. 1993, Vol 92, Num 3, pp 1580-1586, issn 0021-9738Article

Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infectionWESSELING, J. G; GODEKE, G.-J; SCHIJNS, V. E. C. J et al.Journal of general virology. 1993, Vol 74, pp 2061-2069, issn 0022-1317, 10Article

Function and immunogenicity of human parainfluenza virus 3 glycoproteins expressed by recombinant adenovirusesEBATA, S; PREVEC, L; GRAHAM, F. L et al.Virus research. 1992, Vol 24, Num 1, pp 21-33, issn 0168-1702Article

Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusionHUTCHINSON, L; GOLDSMITH, K; SNODDY, D et al.Journal of virology. 1992, Vol 66, Num 9, pp 5603-5609, issn 0022-538XArticle

Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeysPREVEC, L; CHRISTIE, B. S; LAURIE, K. E et al.Journal of acquired immune deficiency syndromes. 1991, Vol 4, Num 6, pp 568-576, issn 0894-9255Article

Isolation and characterization of insertion mutants in E1A of adenovirus type 5BAUTISTA, D. S; HITT, M; MCGRORY, J et al.Virology (New York, NY). 1991, Vol 182, Num 2, pp 578-596, issn 0042-6822Article

Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirius vectorsSCHNEIDER, M; GRAHAM, F. L; PREVEC, L et al.Journal of general virology. 1989, Vol 70, pp 417-427, issn 0022-1317, 2Article

Stable transfer of a mouse dihydrofolate reductase gene into a deficient cell line using human adenovirus vectorGOUTAM GHOSH-CHOUDHURY; GRAHAM, F. L.Biochemical and biophysical research communications (Print). 1987, Vol 147, Num 3, pp 964-973, issn 0006-291XArticle

Nonrandom insertion of Tn5 into cloned human adenovirus DNAMCKINNON, R. D; WAYE, J. S; BAUTISTA, D. S et al.Gene (Amsterdam). 1985, Vol 40, Num 1, pp 31-38, issn 0378-1119Article

Intracellular localization of adenovirus type 5 tumor antigens in productively infected cells = Localisation intracellulaire des antigènes tumoraux de l'adénovirus type 5 dans les cellules après infection productiveROWE, D. T; GRAHAM, F. L; BRANTON, P. E et al.Virology (New York, NY). 1983, Vol 129, Num 2, pp 456-468, issn 0042-6822Article

Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectorsSARGENT, K. L; NG, P; EVELEGH, C et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 6, pp 504-511, issn 0969-7128, 8 p.Article

Genome-wide scan for adult onset primary open angle glaucomaWIGGS, J. L; ALLINGHAM, R. R; HAINES, J. L et al.Human molecular genetics (Print). 2000, Vol 9, Num 7, pp 1109-1117, issn 0964-6906Article

Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectorsPASTORE, L; MORRAL, N; HESHAN ZHOU et al.Human gene therapy. 1999, Vol 10, Num 11, pp 1773-1781, issn 1043-0342Article

A high-efficiency Cre/loxP-based system for construction of adenoviral vectorsNG, P; PARKS, R. J; CUMMINGS, D. T et al.Human gene therapy. 1999, Vol 10, Num 16, pp 2667-2672, issn 1043-0342Article

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicitySCHIEDNER, G; MORRAL, N; PARKS, R. J et al.Nature genetics. 1998, Vol 18, Num 2, pp 180-183, issn 1061-4036Article

Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7scBOTH, G. W; LOCKETT, L. J; VIJAYALAKSHMI JANARDHANA et al.Virology (New York, NY). 1993, Vol 193, Num 2, pp 940-950, issn 0042-6822Article

The cleavage site of restriction endonuclease mnlIBRINKLEY, P; BAUTISTA, D. S; GRAHAM, F. L et al.Gene (Amsterdam). 1991, Vol 100, pp 267-268, issn 0378-1119, 2 p.Article

The effect of E1 mutations on biochemical transformation by an adenovirus carrying the herpes simplex virus thymidine kinase gene in region E3WILSON, G. M; GRAHAM, F. L.Virus research. 1989, Vol 13, Num 1, pp 29-44, issn 0168-1702Article

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5MCGRORY, W. J; BAUTISTA, D. S; GRAHAM, F. L et al.Virology (New York, NY). 1988, Vol 163, Num 2, pp 614-617, issn 0042-6822, 4 p.Article